SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001477932-19-000446
Filing Date
2019-02-13
Accepted
2019-02-13 12:59:41
Documents
46
Period of Report
2018-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q nbio_10q.htm 10-Q 162933
2 CERTIFICATION nbio_ex311.htm EX-31.1 7752
3 CERTIFICATION nbio_ex312.htm EX-31.2 7743
4 CERTIFICATION nbio_ex321.htm EX-32.1 3043
5 CERTIFICATION nbio_ex322.htm EX-32.2 3244
  Complete submission text file 0001477932-19-000446.txt   1513880

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT nbio-20181231.xml EX-101.INS 203567
7 XBRL TAXONOMY EXTENSION SCHEMA nbio-20181231.xsd EX-101.SCH 30306
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE nbio-20181231_cal.xml EX-101.CAL 26331
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE nbio-20181231_def.xml EX-101.DEF 97575
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE nbio-20181231_lab.xml EX-101.LAB 143723
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nbio-20181231_pre.xml EX-101.PRE 143919
Mailing Address 601 21ST STREET SUITE 300 VERO BEACH FL 32960
Business Address 601 21ST STREET SUITE 300 VERO BEACH FL 32960 612-961-5656
Nascent Biotech Inc. (Filer) CIK: 0001622057 (see all company filings)

IRS No.: 450612715 | State of Incorp.: NV | Fiscal Year End: 0331
Type: 10-Q | Act: 34 | File No.: 000-55299 | Film No.: 19595690
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1